Letybo® Advanced Facial Treatment in Mason, Ohio
Regenerative Aesthetics offers Letybo® treatment in Mason, Ohio for adults seeking a personalized injectable approach to moderate to severe frown lines between the eyebrows.
Letybo® (letibotulinumtoxinA-wlbg) is an FDA-approved botulinum toxin type A neuromodulator. It works by temporarily reducing the muscle activity responsible for creating glabellar lines, commonly known as frown lines or “11 lines.”
FDA-approved in the United States in 2024, Letybo® provides another neuromodulator option for patients interested in softening dynamic facial lines while maintaining a personalized and natural-looking treatment approach.
Every treatment begins with an individual facial assessment. Your provider evaluates your facial anatomy, muscle movement, line severity, previous injectable treatments, medical history, and aesthetic goals before determining whether Letybo® is appropriate.
Regenerative Aesthetics welcomes patients from Mason, Cincinnati, West Chester, Deerfield Township, and surrounding Southwest Ohio communities.
What Is Letybo®?
Letybo® is a prescription injectable neuromodulator containing letibotulinumtoxinA-wlbg, a botulinum toxin type A.
It is classified as an acetylcholine release inhibitor and neuromuscular blocking agent. When injected into selected facial muscles, it temporarily reduces the signals that cause those muscles to contract.
In the United States, Letybo® is FDA-approved for the temporary improvement of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adults.
Letybo® was approved by the FDA on February 29, 2024, adding another FDA-approved botulinum toxin option for aesthetic treatment of frown lines.
How Does Letybo® Work?
Facial expressions such as frowning repeatedly activate muscles between the eyebrows. Over time, repeated contraction of the corrugator and procerus muscles can contribute to visible glabellar lines.
Letybo® is injected directly into selected muscles involved in these expressions. The medication temporarily inhibits acetylcholine release at the neuromuscular junction, reducing targeted muscle activity.
As contraction of the treated muscles decreases, the appearance of dynamic frown lines can become smoother.
The effect is temporary, and normal muscle activity gradually returns over time.
Glabellar Lines
Letybo® is FDA-approved for the temporary improvement of moderate to severe glabellar lines in adult patients.
These vertical lines develop between the eyebrows and are often referred to as frown lines or “11 lines.”
Dynamic Frown Lines
Glabellar lines are strongly influenced by repeated contraction of the corrugator and procerus muscles during facial expression.
By temporarily reducing activity in these targeted muscles, Letybo® can soften the appearance of frown lines when the patient frowns.
Individual Facial Assessment
Facial anatomy and muscle activity vary from person to person. Treatment planning therefore begins with an evaluation of your facial movement, line severity, brow position, previous neurotoxin treatments, and desired result.
Letybo® is not FDA-approved in the United States for aesthetic treatment of facial areas other than glabellar lines.
Benefits of Letybo® Treatment
FDA-Approved Treatment
Letybo® is FDA-approved for the temporary improvement of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adults.
Softens Frown Lines
By temporarily reducing targeted muscle activity between the eyebrows, Letybo® can help moderate to severe frown lines appear smoother.
Minimally Invasive Treatment
Letybo® is administered through a series of small intramuscular injections and does not require surgery or incisions.
Personalized Facial Treatment
Treatment planning takes into account facial anatomy, muscle strength, brow position, line severity, previous injectable treatments, and the patient's aesthetic goals.
Temporary, Adjustable Treatment Strategy
The effects of Letybo® are temporary. Muscle activity gradually returns over time, allowing future treatment decisions to be reassessed according to the patient's response and evolving goals.
How Quickly Does Letybo® Work?
How Long Does Letybo® Last?
Letybo® provides temporary rather than permanent reduction of targeted muscle activity.
Treatment response and duration vary among patients. Factors such as muscle strength, individual metabolism, facial anatomy, previous neurotoxin treatments, dose, and treatment response can influence how long the effect remains noticeable.
Your provider will determine an appropriate retreatment schedule based on your individual response rather than automatically treating every patient at the same interval.
What Happens During a Letybo® Treatment?
Your Letybo® appointment begins with a facial assessment and review of your medical history, previous neurotoxin treatments, medications, facial muscle activity, and aesthetic goals.
For the FDA-approved treatment of glabellar lines, Letybo® is administered through small intramuscular injections into muscles between the eyebrows.
The FDA-approved dosing regimen uses five injection sites: two sites in each corrugator muscle and one site in the procerus muscle.
The recommended total dose for treatment of glabellar lines is 20 Units, divided into five injections of 4 Units each.
Your provider uses knowledge of facial anatomy and the approved administration technique when planning and performing treatment.
Letybo® Units Are Unique to Letybo®
Letybo® Units should not be directly compared with or converted into Units of another botulinum toxin product.
Each botulinum toxin product uses its own manufacturing process, biological assay, formulation, and dosing system.
For this reason, a certain number of Letybo® Units does not automatically equal the same number of BOTOX®, Dysport®, Xeomin®, Jeuveau®, or another botulinum toxin product.
Treatment should be prescribed and administered according to the dosing information specific to the product being used.
Letybo® vs. BOTOX®, Dysport® and Xeomin®
Letybo®, BOTOX® Cosmetic, Dysport®, and Xeomin® are all botulinum toxin products used in aesthetic medicine, but they are different prescription products.
They differ in formulation, manufacturing process, approved indications, dosing systems, and other product-specific characteristics.
There is no single neurotoxin that is automatically the best choice for every patient.
Your previous treatment experience, facial anatomy, muscle activity, treatment goals, medical history, and provider assessment may all influence which product is selected.
Importantly, the dosing Units of these products are not directly interchangeable or convertible.
BOTOX®, Xeomin®, or Dysport®: Which Is Right for Me?
Letybo® and the Korean Aesthetic Experience
Letybo® was developed in South Korea and became available internationally before receiving FDA approval in the United States in 2024.
The product has an established international history in aesthetic medicine and is now available as an additional FDA-approved neuromodulator option for appropriate U.S. patients with moderate to severe glabellar lines.
At Regenerative Aesthetics, the origin or popularity of a product is not used as the sole reason to recommend treatment. Product selection remains based on medical appropriateness, facial anatomy, previous treatment response, and individual aesthetic goals.
Can Letybo® Create Natural-Looking Results?
The goal of a personalized neurotoxin treatment is not necessarily to eliminate all facial movement.
Treatment can be planned according to your anatomy, muscle activity, frown-line severity, and desired aesthetic outcome.
For some patients, the goal is a visibly smoother glabellar area while maintaining an expressive and balanced overall appearance.
Individual results vary, and no injectable treatment can guarantee a specific aesthetic outcome.
Who May Be a Candidate for Letybo®?
Letybo® may be considered for adults with moderate to severe glabellar lines associated with activity of the corrugator and/or procerus muscles.
Before treatment, your provider will review your medical history, medications, previous botulinum toxin treatments, facial anatomy, muscle strength, and treatment goals.
Tell your provider if you have experienced side effects from another botulinum toxin treatment, have swallowing or breathing difficulties, neuromuscular disorders, bleeding problems, cardiovascular conditions, weakness of facial muscles, drooping eyelids, previous facial surgery, or other relevant medical conditions.
You should also tell your provider about all prescription medications, over-the-counter medications, vitamins, supplements, and any botulinum toxin treatment you have received previously.
Who Should Not Receive Letybo®?
Letybo® is contraindicated in patients with a known hypersensitivity to any botulinum toxin preparation or to any component of the Letybo® formulation.
Treatment should also not be administered when an infection is present at the proposed injection site.
Additional medical conditions or medications may require caution or may make treatment inappropriate.
An individual medical assessment is necessary before treatment.
Possible Side Effects of Letybo®
As with other prescription botulinum toxin treatments, Letybo® can cause side effects.
In the clinical trials supporting FDA approval, the most commonly reported adverse reaction was headache. Brow ptosis, eyelid ptosis, and blepharospasm were also reported in a small number of treated patients.
Temporary injection-site effects may also occur following an injectable treatment.
Tell your provider if you experience concerning or unexpected symptoms following treatment.
Important Letybo® Safety Information
All botulinum toxin products, including Letybo®, carry a Boxed Warning regarding the potential distant spread of toxin effect.
Effects may spread from the injection area and produce symptoms consistent with botulinum toxin effects hours to weeks after treatment.
These symptoms can include generalized muscle weakness, double vision, drooping eyelids, difficulty speaking, difficulty swallowing, or breathing difficulties.
Swallowing and breathing difficulties can be life-threatening. Seek immediate medical attention if you develop difficulty breathing, speaking, or swallowing after treatment.
Your provider will review relevant risks and medical history before Letybo® is administered.
Why Choose Regenerative Aesthetics for Letybo® in Mason, Ohio?
At Regenerative Aesthetics, Letybo® treatment begins with an individualized facial assessment rather than a standardized injection plan.
Our approach considers facial anatomy, muscle movement, line severity, brow position, previous injectable treatments, medical history, and your desired level of correction before recommending treatment.
Because our practice offers multiple injectable and skin-rejuvenation options, your consultation can also help determine whether a neuromodulator alone or a broader facial rejuvenation strategy is appropriate for your goals.
Our priority is personalized treatment planning, appropriate product selection, realistic expectations, and natural-looking facial balance.
Regenerative Aesthetics welcomes patients from Mason, Cincinnati, West Chester, Deerfield Township, and surrounding Southwest Ohio communities.
Letybo® as Part of an Advanced Facial Treatment Plan
Dynamic wrinkles are only one component of facial aging.
Depending on your individual concerns, your facial rejuvenation plan may also consider skin texture, pigmentation, volume changes, collagen loss, sun damage, hydration, or other aspects of skin quality.
Letybo® may therefore be used as one component of a personalized aesthetic plan when treatment of moderate to severe glabellar lines is appropriate.
Other treatments offered at Regenerative Aesthetics include dermal fillers, Scarlet Pro RF Microneedling, NOUVADerm™ fractional laser, DYE-VL IPL, HydraFacial MD®, and other individualized facial treatments.
Treatments do not necessarily need to be performed during the same appointment. Appropriate sequencing and timing are determined according to your treatment plan.
Frequently Asked Questions About Letybo®
What is Letybo®?
Letybo® (letibotulinumtoxinA-wlbg) is an FDA-approved botulinum toxin type A prescription medicine used in adults to temporarily improve moderate to severe frown lines between the eyebrows.
Is Letybo® FDA-approved?
Yes. Letybo® received U.S. FDA approval on February 29, 2024 for the temporary improvement of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adults.
What areas is Letybo® FDA-approved to treat?
In the United States, Letybo® is FDA-approved for moderate to severe glabellar lines between the eyebrows. It is not FDA-approved for other aesthetic treatment areas.
How does Letybo® work?
Letybo® temporarily reduces targeted muscle activity by inhibiting acetylcholine release at the neuromuscular junction. This can soften dynamic frown lines produced by repeated muscle contraction.
How quickly does Letybo® start working?
Some patients may begin noticing improvement within the first few days, but individual onset varies. Clinical studies evaluated important treatment outcomes at Week 4.
How long does Letybo® last?
Treatment effects are temporary and duration varies among patients. Letybo® should not be administered more frequently than every three months according to U.S. prescribing information.
How many Units of Letybo® are used for frown lines?
The FDA-approved dose for glabellar lines is a total of 20 Letybo® Units, divided into five intramuscular injections of 4 Units each.
Are Letybo® Units the same as BOTOX® Units?
No. Letybo® dosing Units are specific to Letybo® and cannot be directly compared with or converted into Units of BOTOX®, Dysport®, Xeomin®, or another botulinum toxin product.
Is Letybo® the same as BOTOX®?
No. Both are botulinum toxin type A neuromodulators, but Letybo® and BOTOX® Cosmetic are different prescription products with their own formulations, manufacturing processes, approved indications, and dosing systems.
How often can I receive Letybo®?
Letybo® should not be administered more frequently than every three months. Your provider will recommend retreatment based on your individual response and treatment goals.
What are the common side effects of Letybo®?
Headache was the most common adverse reaction reported in clinical trials. Less commonly reported reactions included brow ptosis, eyelid ptosis, and blepharospasm.
Can I receive Letybo® if I previously had another neurotoxin?
Possibly, but tell your provider about every previous botulinum toxin treatment, including the product used and when it was administered. This information is important for safe treatment planning.
Is there downtime after Letybo®?
Letybo® is a minimally invasive injectable treatment, but individual responses vary. Your provider will give you specific post-treatment instructions and explain any temporary effects you may experience.
Can Letybo® completely remove frown lines?
Letybo® temporarily improves the appearance of appropriate glabellar lines, but complete elimination of every line cannot be guaranteed. Results depend on muscle activity, line severity, skin characteristics, and individual response.
Schedule Your Letybo® Consultation in Mason, Ohio
Interested in discovering whether Letybo® is the right neurotoxin for your facial aesthetic goals?
Schedule a personalized consultation at Regenerative Aesthetics in Mason, Ohio. Our team will evaluate your facial anatomy, muscle activity, glabellar line severity, previous injectable treatments, medical history, and desired results before recommending an appropriate treatment plan.
Regenerative Aesthetics
969 Reading Rd N
Mason, OH 45040
Phone: (513) 204-44-83
Email: contact@regenspa.org